000 | 01719 a2200433 4500 | ||
---|---|---|---|
005 | 20250517013810.0 | ||
264 | 0 | _c20151117 | |
008 | 201511s 0 0 eng d | ||
022 | _a2046-4924 | ||
024 | 7 |
_a10.3310/hta19080 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLong, Linda | |
245 | 0 | 0 |
_aWhat is the clinical effectiveness and cost-effectiveness of conservative interventions for tendinopathy? An overview of systematic reviews of clinical effectiveness and systematic review of economic evaluations. _h[electronic resource] |
260 |
_bHealth technology assessment (Winchester, England) _cJan 2015 |
||
300 |
_a1-134 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review; Systematic Review | ||
650 | 0 | 4 |
_aBotulinum Toxins _xeconomics |
650 | 0 | 4 | _aCost-Benefit Analysis |
650 | 0 | 4 | _aElbow Joint |
650 | 0 | 4 |
_aGlucocorticoids _xeconomics |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHyaluronic Acid _xeconomics |
650 | 0 | 4 |
_aLow-Level Light Therapy _xadverse effects |
650 | 0 | 4 | _aModels, Econometric |
650 | 0 | 4 |
_aPain Management _xeconomics |
650 | 0 | 4 | _aPhysical Therapy Modalities |
650 | 0 | 4 | _aQuality of Life |
650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
650 | 0 | 4 |
_aSclerosing Solutions _xeconomics |
650 | 0 | 4 |
_aTendinopathy _xeconomics |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 |
_aUltrasonic Therapy _xadverse effects |
700 | 1 | _aBriscoe, Simon | |
700 | 1 | _aCooper, Chris | |
700 | 1 | _aHyde, Chris | |
700 | 1 | _aCrathorne, Louise | |
773 | 0 |
_tHealth technology assessment (Winchester, England) _gvol. 19 _gno. 8 _gp. 1-134 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.3310/hta19080 _zAvailable from publisher's website |
999 |
_c24573152 _d24573152 |